NSE - Delayed Quote INR

Aurobindo Pharma Limited (AUROPHARMA.NS)

Compare
1,447.60 -12.65 (-0.87%)
At close: 3:30 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 75.67B
Earnings 9.19B
?

Analyst Price Targets

790.00 Low
953.00 Average
1,447.60 Current
1,200.00

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
No. of Analysts 222525
Avg. Estimate 1414.1755.7762.29
Low Estimate 13.313.9447.749.1
High Estimate 14.714.463.5269.28
Year Ago EPS ------55.77

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
No. of Analysts 332625
Avg. Estimate 61.7B63.62B250.11B271.28B
Low Estimate 59.2B62.27B234.74B242.8B
High Estimate 64.52B65.38B268.4B298.66B
Year Ago Sales ------250.11B
Sales Growth (year/est) ------8.50%

Earnings History

CURRENCY IN USD 6/30/2021
EPS Est. --14.53
EPS Actual --13.14
Difference ---1.39
Surprise % ---9.60%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
Current Estimate 1414.1755.7762.29
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days --------
Down Last 30 Days ------1

Growth Estimates

CURRENCY IN USD AUROPHARMA.NSIndustrySectorS&P 500
Current Qtr. ------3.10%
Next Qtr. ------8.00%
Current Year ------2.30%
Next Year 11.70%----13.20%
Next 5 Years (per annum) 11.30%----11.85%
Past 5 Years (per annum) 8.19%------

Related Tickers